1. From the Clinical Trials Group, National Heart, Lung, and Blood Institute, Bethesda, Md (M.J.D., M.K.); Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (M.A.P.); University of Texas School of Public Health, Houston (B.R.D.); and Cardiovascular Engineering, Inc (G.F.M.), Dover, Mass.